Implantable nanosensor for early-stage ovarian cancer detection
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210563
- Recipient
-
Sloan-Kettering Institute For Cancer Research UEI KUKXRCZ6NZC2
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,347,700
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding
-
- $673,850.00 Federal
- $673,850.00 Non-federal
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1,347,700 Project Grant to Sloan-Kettering Institute For Cancer Research under the Military Medical Research and Development program (CFDA 12.420). The grant will support development of an implantable nanosensor for early-stage ovarian cancer detection from June 2022 through June 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will further those goals by funding research into a novel nanosensor that could enable earlier detection of ovarian cancer, improving patient outcomes. The total funding amount of $1,347,700 will support Sloan-Kettering's work developing this promising early detection technology over the three-year period of performance in New York, New York.
Quick answers
Who received award W81XWH2210563?
W81XWH2210563 was awarded to Sloan-Kettering Institute For Cancer Research by Medical Command (Department of the Army) on June 15, 2022.
How much is award W81XWH2210563 worth?
$1,347,700 has been obligated on W81XWH2210563: $673,850 in federal funding and $673,850 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award